Hepatitis B Prevention & Treatment: Research & News
- Chinese Experts Working on New Ways to "Inject" Hepatitis Vaccines (October 12, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Battling Hepatitis in West Africa (August 18, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Breastfeeding OK for Moms With Hepatitis B: Study (May 24, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HHS Announces New Action Plan to Prevent, Care and Treat Viral Hepatitis (May 12, 2011)
From AIDS.gov
- Hepatitis B Linked to Lymphoma in Study (August 4, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis B: Sex Hormone Explains Higher Liver Cancer Risk in Men (June 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- West Virginia Urges Testing After Hepatitis B Outbreak (June 7, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis Highlights From CROI (May/June 2010)
Sexual transmission of hepatitis B, hepatitis C survival in syringes and more.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Join a Rally in Washington, D.C., on May 19 to Call for Hepatitis Program Funding (April 30, 2010)
From Treatment Action Group
- U.S. Lawmakers Push to Ramp Up Hepatitis Battle (November 3, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis B Vaccine Scale-Up and Treatment of HIV/HBV Coinfection Present Challenges (July 28, 2009)
Hepatitis B vaccine coverage has increased dramatically in recent years, but some regions still lag behind and collaboration with broader health programmes would aid scale-up, according to a symposium presentation on viral hepatitis.
From aidsmap.com
- TAG 2009 Pipeline Report (PDF) (July 2009)
From Treatment Action Group
- New FDA Hepatitis List Serve (March 12, 2009)
From U.S. Food and Drug Administration
- Implicit Discrimination Against Chinese Hepatitis B Carriers Rising in Multinationals -- Survey (March 6, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tenofovir Approved for Hepatitis B (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Study Finds Association Between Hepatitis B and Pancreatic Cancer (October 1, 2008)
To read PDF, click here.
In Journal of Clinical Oncology, from American Society of Clinical Oncology
- CDC Expands Testing Recommendations for Chronic Hepatitis B Virus Infection (September 18, 2008)
New guidance also issued on patient management for those infected.
From U.S. Centers for Disease Control and Prevention
- FDA Approves Gilead's Antiretroviral Viread for Use as Hepatitis B Treatment (August 13, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Hep B Doesn't Impact HIV Treatment, Study Finds (May 2008)
In HIV Medicine
- Tenofovir Shows Excellent Promise as a Treatment for Hepatitis B Monoinfection (April 25, 2008)
From aidsmap.com
- HIV/Hepatitis C Coinfection Does Not Influence CD4+ Cell Recovery in Patients on Suppressive HAART (February 5, 2008)
Lars Peters, M.D., discusses his study, which counters long-established assumptions about the effect of HCV/HIV coinfection on immune recovery after patients commence antiretroviral therapy.
From The Body PRO
- Immune Reconstitution May Trigger Hepatic Flares in HIV/Hepatitis B Coinfected Patients Starting HAART (February 5, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- News From the Front (Fall 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
- Baraclude (Entecavir) Warning (PDF) (August 2007)
From Bristol-Myers Squibb Company
- Label Changes for Baraclude (Entecavir) Tablets and Oral Solution (July 25, 2007)
From U.S. Food and Drug Administration
- Tenofovir Appears Effective Against HIV and Hepatitis B in Coinfected People (June 12, 2007)
From aidsmap.com
- False-Negative Hepatitis B Test Results Possible in HIVers (March 27, 2007)
- Important Information Regarding Baraclude (Entecavir) in Patients Co-Infected With HIV and HBV (PDF) (February 2007)
From U.S. Food and Drug Administration
- Fosamprenavir + Ritonavir Appears Safe Through 120 Weeks in HIV/HBV and HIV/HCV-Coinfected Patients (July 26, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- FDA Approves Baraclude (Generic Name: Entecavir) for Treatment of Hepatitis B (March 30, 2005)
[Archived Article]
From U.S. Food and Drug Administration
- Combination Therapy for HBV: Adefovir + FTC Beats Adefovir Alone in Study (January 2005)
[Archived Article]
In Infectious Diseases in Corrections Report, from Brown Medical School
- Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus (HBV) (January 2005)
[Archived Article]
In Infectious Diseases in Corrections Report, from Brown Medical School
- Hepatitis Testing Important for HIVers Before Taking Kaletra (October 13, 2004)
[Archived Article]
From aidsmap.com
- High Rates of Hepatitis B Found Among HIV-Positive People in U.S.; Vaccination Recommended (October 2004)
[Archived Article]
Quick recap of studies in the journals JAIDS and Clinical Infectious Diseases.
In HIV Treatment ALERTS!, from The Center for AIDS
- Hepatitis/HIV Coinfection Linked to Liver Complications in Kaletra Patients (September 2004)
[Archived Article]
Abstract of a study that recommends testing HIV-infected patients for HBV and HCV and measuring their baseline ALT values before lopinavir/ritonavir therapy is begun.
In HIV Medicine
- Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- HBV Infection: Two Drugs Are Better Than One (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- The 39th European Association for the Study of the Liver (April 18, 2004)
[Archived Article]
Browse through the abstracts from this annual meeting.
- CROI 2004 Recap: HIV, HCV and HBV (April 2004)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Hepatitis B a Deadly Threat to U.S. Asians (July/August 2003)
[Archived Article]
In Body Positive, from Body Positive
- Phase III Results of FTC in Hepatitis B and HIV Co-Infected Patients (July 16, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Wyoming: Hepatitis Cases Still Rising (July 15, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First Clinical Care Options for Hepatitis, June 19-22 (May 30, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Gene Therapy May Hold Key to Treating Hepatitis B (May 27, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Canada Resists Mandatory Disease Testing in Prisons (May 16, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Infection Persists After Clinical Recovery in Acute Self-Limited Hepatitis B (May 16, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis B a Deadly Threat to U.S. Asians (April 30, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis B Vaccination Among Research Participants, Seattle, Washington (November 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New Jersey High School Students Required to Receive Hepatitis B Vaccination (October 24, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Hepatitis Immunization Rates Remain Less Than Half for Gay and Bisexual Men (October 23, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves New Treatment for Chronic Hepatitis B (September 20, 2002)
[Archived Article]
From U.S. Food and Drug Administration
- Hepatitis B: FDA Advisers Plug New Drug (September 16, 2002)
[Archived Article]
The failed anti-HIV drug adefovir moves one step closer to FDA approval as a hepatitis B drug.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Lamivudine Is as Effective in HBV Treatment in Children as in Adults (August/September 2002)
[Archived Article]
In HEPP Report, from Brown Medical School
- U.S. Government Panel Backs New Hepatitis Drug; Therapy, Created to Fight AIDS, Works Against Liver Infection (August 7, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Some HIV-Positive People at Greater Risk for Liver Problems (July 24, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Anti-Hepatitis B Virus Activity of Tenofovir Disoproxil Fumarate in Lamivudine Experienced HIV/HBV Co-Infected Patients (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Promising HCV and HBV Treatments (Summer/Autumn 2002)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Is Liver Transplant an Option? (Summer 2002)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
- United States: Hepatitis B on Decline but Many Still at Risk (April 3, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- 9th Retrovirus Conference Coverage: HIV/HBV Co-Infection (Spring 2002)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Important Drug Warning: Intron A (PDF) (December 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Questions for Dr. Brust on HBV Treatment (November/December 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Low-Dose Adefovir for the Treatment of Chronic Hepatitis B in HIV-Infected People (November/December 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- HBV: Lamivudine -- When to Start, When to Stop (October 23, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- Important Drug Warning: Roferon-A (PDF) (September 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Can Vitamin E Help People Recover from Hepatitis B? (June 19, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Combination Therapy for HBV (Hepatitis B) Infections (March 2001)
[Archived Article]
In The PRN Notebook
- Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Manufacturer Ends Adefovir Development (April 2000)
[Archived Article]
In Project Inform Perspective, from Project Inform
- Gilead vs. FDA (Winter 1999/2000)
[Archived Article]
The FDA eviscerates a new drug application.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Death of Adefovir (Winter 1999/2000)
[Archived Article]
Gilead pulls the plug on the drug. Treatment Issues explores what went wrong with its development.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Adefovir Effective in Patients Resistant to ZDV and 3TC (October 1999)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Immune Response to Hepatitis B Spares Liver Cells (April 29, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- 3TC Recommended for Hepatitis B (April 1999)
[Archived Article]
In Body Positive, from Body Positive
- More Trouble for Adefovir (April 1999)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Hepatitis Treatment Update (Winter 1998/1999)
[Archived Article]
Rebetron limits patients' options.
In Notes From the Underground, from PWA Health Group
- A multicenter trial of adefovir when added to standard antiretroviral therapy (September 26, 1998)
[Archived Article]
In The 38th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Adefovir dipivoxil therapy significantly decreases HIV RNA in patients with high level AZT-3TC resistant HIV (September 25, 1998)
[Archived Article]
In The 38th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Adefovir Dipivoxil (PREVEON): New Results with Hepatitis B, HIV (April 17, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- T-20 and Adefovir for Salvage Therapy -- Expect No Miracles (April 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Adefovir: The First Nucleotide Analog (February 1998)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Alright Thymosin! (April 1996)
[Archived Article]
In Notes From the Underground, from PWA Health Group
|
Advertisement
|
Email
Glossary
